$-0.84 EPS Expected for OpGen, Inc. (OPGN)

April 19, 2018 - By Michael Collier

OpGen, Inc. (NASDAQ:OPGN) Logo

Analysts expect OpGen, Inc. (NASDAQ:OPGN) to report $-0.84 EPS on April, 25.They anticipate $3.91 EPS change or 82.32 % from last quarter’s $-4.75 EPS. After having $-1.33 EPS previously, OpGen, Inc.’s analysts see -36.84 % EPS growth. The stock increased 0.97% or $0.02 during the last trading session, reaching $2.09. About 49,440 shares traded. OpGen, Inc. (NASDAQ:OPGN) has declined 93.75% since April 19, 2017 and is downtrending. It has underperformed by 105.30% the S&P500.

OpGen, Inc., a precision medicine company, engages in developing molecular information services and products to combat infectious diseases in the healthcare industry worldwide. The company has market cap of $11.06 million. The firm utilizes molecular diagnostics and bioinformatics to help combat infectious diseases. It currently has negative earnings. It also helps clinicians with information about life threatening infections, enhance patient outcomes, and decrease the spread of infections caused by multidrug-resistant microorganisms.

OpGen, Inc. (NASDAQ:OPGN) Ratings Chart

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our free daily email newsletter: